Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies


Por: Pasquini, MC, Zhang, MJ, Medeiros, BC, Armand, P, Hui, ZH, Nishihori, T, Aljurf, MD, Akpek, G, Cahn, JY, Cairo, MS, Cerny, J, Copelan, EA, Deol, A, Freytes, CO, Gale, RP, Ganguly, S, George, B, Gupta, V, Hale, GA, Kamble, RT, Klumpp, TR, Lazarus, HM, Luger, SM, Liesveld, JL, Litzow, MR, Marks, DI, Martino, R, Norkin, M, Olsson, RF, Oran, B, Pawarode, A, Pulsipher, MA, Ramanathan, M, Reshef, R, Saad, AA, Saber, W, Savani, BN, Schouten, HC, Ringden, O, Tallman, MS, Uy, GL, Wood, WA, Wirk, B, Perez, WS, Batiwalla, M, Weisdorf, DJ

Publicada: 1 feb 2016
Resumen:
The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. MK+AML was associated with higher disease relapse (hazard ratio, 1.98; P < .01), similar transplantation-related mortality (TRM) (hazard ratio, 1.01; P = .90), and worse survival (hazard ratio, 1.67; P < .01) compared with those outcomes for other cytogenetically defined AML. Among patients with MDS, MK+ MDS was associated with higher disease relapse (hazard ratio, 2.39; P < .01), higher TRM (hazard ratio, 1.80; P < .01), and worse survival (HR, 2.02; P < .01). Subset analyses comparing chromosome 7 abnormalities (del7/7q) with or without MK+ demonstrated higher mortality for MK+ disease in for both AML (hazard ratio, 1.72; P < .01) and MDS (hazard ratio, 1.79; P < .01). The strong negative impact of MK+ in myeloid malignancies was observed in all age groups and using either myeloablative or reduced-intensity conditioning regimens. Alternative approaches to mitigate disease relapse in this population are needed. (C) 2016 American Society for Blood and Marrow Transplantation.

Filiaciones:
Pasquini, MC:
 Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

Zhang, MJ:
 Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

 Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA

Medeiros, BC:
 Stanford Univ, Sch Med, Dept Hematol, Stanford, CA 94305 USA

Armand, P:
 Dana Farber Canc Inst, Dept Med Oncol Hematol Malignancies, Boston, MA 02115 USA

Hui, ZH:
 Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

Nishihori, T:
 H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL USA

Aljurf, MD:
 King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia

Akpek, G:
 Banner MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy Program, Gilbert, AZ USA

Cahn, JY:
 Univ Hosp, Dept Hematol, Grenoble, France

Cairo, MS:
 New York Med Coll, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA

Cerny, J:
 UMass Mem Med Ctr, Dept Med, Worcester, MA USA

Copelan, EA:
 Carolinas HealthCare Syst, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA

Deol, A:
 Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI USA

Freytes, CO:
 S Texas Vet Hlth Care Syst, Div Hematol & Oncol, San Antonio, TX USA

 Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

Gale, RP:
 Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Hematol Res Ctr, London, England

Ganguly, S:
 Univ Kansas, Med Ctr, Div Hematol & Oncol, Blood & Marrow Transplantat, Kansas City, KS 66103 USA

George, B:
 Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India

Gupta, V:
 Univ Hlth Network, Princess Margaret Canc Ctr, Blood & Marrow Transplant Program, Toronto, ON, Canada

Hale, GA:
 Univ S Florida, All Childrens Hosp, Dept Hematol Oncol, St Petersburg, FL 33701 USA

Kamble, RT:
 Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA

Klumpp, TR:
 Thomas Jefferson Univ Hosp, Dept Med Oncol, Philadelphia, PA 19107 USA

Lazarus, HM:
 Univ Hosp Case Med Ctr, Seidman Canc Ctr, Cleveland, OH USA

Luger, SM:
 Univ Penn, Med Ctr, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA

Liesveld, JL:
 Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA

Litzow, MR:
 Mayo Clin, Div Hematol & Transplant Ctr, Rochester, MN USA

Marks, DI:
 Univ Hosp Bristol NHS Trust, Pediat Bone Marrow Transplant, Bristol, Avon, England

Martino, R:
 Hosp Santa Creu & Sant Pau, Div Clin Hematol, Barcelona, Spain

Norkin, M:
 Univ Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA

Olsson, RF:
 Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden

 Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden

Oran, B:
 Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA

Pawarode, A:
 Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA

Pulsipher, MA:
 Univ So Calif, Keck Sch Med, Childrens Hosp Angeles, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90033 USA

Ramanathan, M:
 UMass Mem Med Ctr, Dept Med, Worcester, MA USA

Reshef, R:
 Univ Penn, Med Ctr, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA

Saad, AA:
 Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA

Saber, W:
 Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

Savani, BN:
 Vanderbilt Univ, Dept Med, Div Hematol Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA

Schouten, HC:
 Acad Ziekenhuis, Dept Hematol, Maastricht, Netherlands

Ringden, O:
 Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden

 Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden

Tallman, MS:
 Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

Uy, GL:
 Washington Univ, Sch Med, Div Oncol, St Louis, MO USA

Wood, WA:
 Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC USA

Wirk, B:
 Seattle Canc Care Alliance, Div Bone Marrow Transplant, Seattle, WA USA

Perez, WS:
 Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

Batiwalla, M:
 NHLBI, NIH, Hematol Branch, Bldg 10, Bethesda, MD 20892 USA

Weisdorf, DJ:
 Univ Minnesota, Med Ctr, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
ISSN: 10838791





BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Editorial
ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 22 Número: 2
Páginas: 248-257
WOS Id: 000369042100010
ID de PubMed: 26327629
imagen Green Accepted, Hybrid Gold

MÉTRICAS